Stereotaxis appoints Burkhardt from Cleveland Clinic as CMO

TriMed Staff | | Health Imaging | Artificial Intelligence
Stereotaxis has appointed J. David Burkhardt, MD, FACC, as chief medical officer (CMO).

Burkhardt was most recently the associate program director for the clinical cardiac electrophysiology fellowship training program and he directed the clinical electrophysiology curriculum at the Lerner Case Western Reserve School of Medicine at the Cleveland Clinic, according to the St. Louis-based Stereotaxis.

Burkhardt is board certified in internal medicine, cardiovascular medicine and clinical cardiac electrophysiology, the company said.

TriMed Staff

Related Content

Deep learning-based reconstructions nearly halve acquisition time of spinal MRIs
Experts highlight 'significant concerns' with fluctuating accuracy of popular large language models
FDA clears AI screening tool for cardiac amyloidosis
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Deep learning reconstruction cuts radiation and contrast dose by half in aortic CTA exams

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.